Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Peripheral nerve transfers change target muscle structure and function.

Bergmeister KD, Aman M, Muceli S, Vujaklija I, Manzano-Szalai K, Unger E, Byrne RA, Scheinecker C, Riedl O, Salminger S, Frommlet F, Borschel GH, Farina D, Aszmann OC.

Sci Adv. 2019 Jan 2;5(1):eaau2956. doi: 10.1126/sciadv.aau2956. eCollection 2019 Jan.

2.

CCR6 controls autoimmune but not innate immunity-driven experimental arthritis.

Bonelli M, Puchner A, Göschl L, Hayer S, Niederreiter B, Steiner G, Tillmann K, Plasenzotti R, Podesser B, Georgel P, Smolen J, Scheinecker C, Blüml S.

J Cell Mol Med. 2018 Nov;22(11):5278-5285. doi: 10.1111/jcmm.13783. Epub 2018 Aug 22.

3.

How does abatacept really work in rheumatoid arthritis?

Bonelli M, Scheinecker C.

Curr Opin Rheumatol. 2018 May;30(3):295-300. doi: 10.1097/BOR.0000000000000491.

PMID:
29401118
4.

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.

Bonelli M, Göschl L, Blüml S, Karonitsch T, Hirahara K, Ferner E, Steiner CW, Steiner G, Smolen JS, Scheinecker C.

Rheumatology (Oxford). 2016 Apr;55(4):710-20. doi: 10.1093/rheumatology/kev403. Epub 2015 Dec 16.

PMID:
26672908
5.

Author Response: Analytic Formulas on Factors Determining the Safety and Efficacy in UV-Light-Sensitized Corneal Cross-Linking.

Laggner M, Pollreisz A, Schmidinger G, Byrne RA, Scheinecker C, Schmidt-Erfurth U, Chen YT.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5742. doi: 10.1167/iovs.15-17718. No abstract available.

PMID:
26325412
6.

Correlation Between Multimodal Microscopy, Tissue Morphology, and Enzymatic Resistance in Riboflavin-UVA Cross-Linked Human Corneas.

Laggner M, Pollreisz A, Schmidinger G, Byrne RA, Scheinecker C, Schmidt-Erfurth U, Chen YT.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3584-92. doi: 10.1167/iovs.15-16508.

PMID:
26047045
7.

Blockade of co-stimulation in chronic inflammatory diseases.

Scheinecker C.

Wien Med Wochenschr. 2015 Jan;165(1-2):23-7. doi: 10.1007/s10354-014-0313-x. Epub 2014 Oct 1. Review.

PMID:
25271110
8.

Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.

Köffel R, Meshcheryakova A, Warszawska J, Hennig A, Wagner K, Jörgl A, Gubi D, Moser D, Hladik A, Hoffmann U, Fischer MB, van den Berg W, Koenders M, Scheinecker C, Gesslbauer B, Knapp S, Strobl H.

Blood. 2014 Oct 23;124(17):2713-24. doi: 10.1182/blood-2014-07-588178. Epub 2014 Sep 11. Erratum in: Blood. 2015 Feb 5;125(6):1049.

9.

CD4⁺CD25⁻Foxp3⁺ T cells: a marker for lupus nephritis?

Bonelli M, Göschl L, Blüml S, Karonitsch T, Steiner CW, Steiner G, Smolen JS, Scheinecker C.

Arthritis Res Ther. 2014 Apr 28;16(2):R104. doi: 10.1186/ar4553.

10.

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis.

Bonelli M, Ferner E, Göschl L, Blüml S, Hladik A, Karonitsch T, Kiener HP, Byrne R, Niederreiter B, Steiner CW, Rath E, Bergmann M, Smolen JS, Scheinecker C.

Arthritis Rheum. 2013 Mar;65(3):599-607. doi: 10.1002/art.37787.

11.

A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis model.

Byrne R, Rath E, Hladik A, Niederreiter B, Bonelli M, Frantal S, Smolen JS, Scheinecker C.

PLoS One. 2012;7(4):e35194. doi: 10.1371/journal.pone.0035194. Epub 2012 Apr 18.

12.

Targeting TNF receptors in rheumatoid arthritis.

Blüml S, Scheinecker C, Smolen JS, Redlich K.

Int Immunol. 2012 May;24(5):275-81. doi: 10.1093/intimm/dxs047. Epub 2012 Mar 28. Review.

PMID:
22457216
13.

Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC).

Herman S, Krenbek D, Klimas M, Bonelli M, Steiner CW, Pietschmann P, Smolen JS, Scheinecker C.

Int Immunol. 2012 Jul;24(7):417-26. doi: 10.1093/intimm/dxs039. Epub 2012 Feb 24.

PMID:
22366044
14.

Heme oxygenase-1 end-products carbon monoxide and biliverdin ameliorate murine collagen induced arthritis.

Bonelli M, Savitskaya A, Steiner CW, Rath E, Bilban M, Wagner O, Bach FH, Smolen JS, Scheinecker C.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):73-8. Epub 2012 Mar 6.

PMID:
22325451
15.

Effects of 18β-Glycyrrhetinic acid in hTNFtg mice - a model of rheumatoid arthritis.

Puchner A, Hayer S, Niederreiter B, Hladik A, Blueml S, Bonelli M, Scheinecker C, Smolen J, Redlich K.

Wien Klin Wochenschr. 2012 Mar;124(5-6):170-6. doi: 10.1007/s00508-011-0103-z. Epub 2012 Jan 3.

PMID:
22210441
16.

Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) and CD99 are critical in lymphatic transmigration of human dendritic cells.

Torzicky M, Viznerova P, Richter S, Strobl H, Scheinecker C, Foedinger D, Riedl E.

J Invest Dermatol. 2012 Apr;132(4):1149-57. doi: 10.1038/jid.2011.420. Epub 2011 Dec 22. Erratum in: J Invest Dermatol. 2012 Jul;132(7):1938.

17.

Rheumatoid arthritis in 2010: from the gut to the joint.

Scheinecker C, Smolen JS.

Nat Rev Rheumatol. 2011 Feb;7(2):73-5. doi: 10.1038/nrrheum.2010.226. Review. No abstract available.

PMID:
21289609
18.

Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.

Scheinecker C, Bonelli M, Smolen JS.

J Autoimmun. 2010 Nov;35(3):269-75. doi: 10.1016/j.jaut.2010.06.018. Epub 2010 Jul 16. Review.

PMID:
20638240
19.

Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.

Blüml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E, Bilban M, Smolen JS, Superti-Furga G, Redlich K.

Arthritis Rheum. 2010 Jun;62(6):1608-19. doi: 10.1002/art.27399.

20.

Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Kueng HJ, Manta C, Haiderer D, Leb VM, Schmetterer KG, Neunkirchner A, Byrne RA, Scheinecker C, Steinberger P, Seed B, Pickl WF.

FASEB J. 2010 May;24(5):1572-82. doi: 10.1096/fj.09-137281. Epub 2010 Jan 7.

21.

Treg and lupus.

Bonelli M, Smolen JS, Scheinecker C.

Ann Rheum Dis. 2010 Jan;69 Suppl 1:i65-66. doi: 10.1136/ard.2009.117135. Review.

PMID:
19995748
22.

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.

Arthritis Rheum. 2009 May;60(5):1463-71. doi: 10.1002/art.24449.

23.

Tocilizumab.

Scheinecker C, Smolen J, Yasothan U, Stoll J, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Apr;8(4):273-4. doi: 10.1038/nrd2863. No abstract available.

PMID:
19337270
24.

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.

Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C.

J Immunol. 2009 Feb 1;182(3):1689-95.

25.

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).

Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.

Int Immunol. 2008 Jul;20(7):861-8. doi: 10.1093/intimm/dxn044. Epub 2008 May 9.

PMID:
18469329
26.

Cytokines as therapeutic targets: advances and limitations.

Scheinecker C, Redlich K, Smolen JS.

Immunity. 2008 Apr;28(4):440-4. doi: 10.1016/j.immuni.2008.03.005. Review.

27.

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.

Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF.

Arthritis Res Ther. 2008;10(1):201. doi: 10.1186/ar2338. Epub 2008 Jan 18. Review.

28.

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.

Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C.

Ann Rheum Dis. 2008 May;67(5):664-71. Epub 2007 Aug 29.

PMID:
17728327
29.

TNF-induced structural joint damage is mediated by IL-1.

Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, van den Berg W, Schett G.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11742-7. Epub 2007 Jul 3.

30.

Dickkopf-1 is a master regulator of joint remodeling.

Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G.

Nat Med. 2007 Feb;13(2):156-63. Epub 2007 Jan 21.

PMID:
17237793
31.

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN.

Nature. 2006 Apr 13;440(7086):890-5.

PMID:
16612374
32.

Application of in vivo microscopy: evaluating the immune response in living animals.

Scheinecker C.

Arthritis Res Ther. 2005;7(6):246-52. Epub 2005 Oct 19. Review.

33.

Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients.

Köller M, Zwölfer B, Steiner G, Smolen JS, Scheinecker C.

Int Immunol. 2004 Nov;16(11):1595-604. Epub 2004 Sep 20.

PMID:
15381672
34.

Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.

Scheinecker C, McHugh R, Shevach EM, Germain RN.

J Exp Med. 2002 Oct 21;196(8):1079-90.

35.

Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.

Fritsch R, Eselböck D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, Tohidast-Akrad M, Hayer S, Neumüller J, Pinol-Roma S, Smolen JS, Steiner G.

J Immunol. 2002 Jul 15;169(2):1068-76.

36.

Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.

Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS.

Arthritis Rheum. 2001 Apr;44(4):856-65.

37.

Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation.

Riedl E, Stöckl J, Majdic O, Scheinecker C, Knapp W, Strobl H.

Blood. 2000 Dec 15;96(13):4276-84.

38.

Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells.

Riedl E, Stöckl J, Majdic O, Scheinecker C, Rappersberger K, Knapp W, Strobl H.

J Immunol. 2000 Aug 1;165(3):1381-6.

39.
40.

Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.

Strobl H, Scheinecker C, Riedl E, Csmarits B, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

J Immunol. 1998 Jul 15;161(2):740-8.

41.

Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis.

Leeb BF, Scheinecker C, Schweitzer H, Smolen JS.

Br J Rheumatol. 1998 May;37(5):586-7. No abstract available.

PMID:
9651097
42.

Analysis of myeloid-associated genes in human hematopoietic progenitor cells.

Bello-Fernández C, Matyash M, Strobl H, Scheinecker C, Knapp W.

Exp Hematol. 1997 Oct;25(11):1158-66.

PMID:
9328452
43.

MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.

Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M, Stöckl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W.

J Immunol. 1997 Mar 1;158(5):2107-15.

PMID:
9036955
44.

TGF-beta 1 dependent generation of LAG+ dendritic cells from CD34+ progenitors in serum-free medium.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

Adv Exp Med Biol. 1997;417:161-5. No abstract available.

PMID:
9286354
45.

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.

Pickl WF, Majdic O, Kohl P, Stöckl J, Riedl E, Scheinecker C, Bello-Fernandez C, Knapp W.

J Immunol. 1996 Nov 1;157(9):3850-9.

PMID:
8892615
46.

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Majdic O, Knapp W.

J Immunol. 1996 Aug 15;157(4):1499-507.

PMID:
8759731
47.

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.

Batard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Bühring HJ, Monier MN, Kukk E, Partanen J, Matikainen MT, Alitalo R, Hatzfeld J, Alitalo K.

Blood. 1996 Mar 15;87(6):2212-20.

48.

Granulomonocyte-associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells.

Scheinecker C, Strobl H, Fritsch G, Csmarits B, Krieger O, Majdic O, Knapp W.

Blood. 1995 Dec 1;86(11):4115-23.

49.

Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis.

Strobl H, Scheinecker C, Csmarits B, Majdic O, Knapp W.

Br J Haematol. 1995 Aug;90(4):774-82.

PMID:
7669655
50.

Molecular characterization of CD34+ human hematopoietic progenitor cells.

Knapp W, Strobl H, Scheinecker C, Bello-Fernandez C, Majdic O.

Ann Hematol. 1995 Jun;70(6):281-96. Review. No abstract available.

PMID:
7543291

Supplemental Content

Loading ...
Support Center